logo-loader
RNS
Vesuvius Plc

Vesuvius plc - Change in Director's Details

RNS Number : 5003L
Vesuvius plc
30 April 2020
 

Vesuvius plc

30 April 2020                                                                                                                                       

 

Notification of Change in Director's Details

 

Vesuvius plc announces that Douglas Hurt, Senior Independent Director and Chair of the Audit Committee of the Company, has been appointed as an independent non-executive director of Hikma Pharmaceuticals PLC effective 1 May 2020.

 

This notification is made in accordance with paragraph 9.6.14R of the Listing Rules.

 

For further information please contact:

 

Henry Knowles, General Counsel and Company Secretary

+44 (0) 20 7822 0000

Pamela Antay, Head of Investor Relations

+44 (0) 7827 802277

 

Vesuvius plc, 165 Fleet Street, London EC4A 2AE

Registered in England and Wales No. 8217766

LEI: 213800ORZ521W585SY02

www.vesuvius.com

 

 

About Vesuvius plc

 

Vesuvius is a global leader in molten metal flow engineering and technology, serving process industries operating in challenging high-temperature conditions.

 

We develop innovative and customised solutions, often used in extremely demanding industrial environments, which enable our customers to improve their manufacturing processes, enhance product quality and reduce energy consumption.  These include flow control solutions, advanced refractories and other consumable products and increasingly, related technical services including data capture.

 

We have a worldwide presence.  We serve our customers through a network of low-cost manufacturing plants located close to their own facilities, and embed our industry experts within their operations, who are all supported by our global technology centres.

 

Our core competitive strengths are our market and technology leadership, strong customer relationships, well established presence in developing markets and our global reach, all of which facilitate the expansion of our addressable markets.

 

Our ultimate goal is to create value for our customers, and to deliver sustainable, profitable growth for our shareholders giving a superior return on their investment whilst providing each of our employees with a safe workplace where he or she is recognised, developed and properly rewarded.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RDNIMMMTMTTJBFM
NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...

FOR OUR FULL DISCLAIMER CLICK HERE

2 min read